Marietta Investment Partners LLC Eli Lilly & CO Transaction History

Marietta Investment Partners LLC

$461 Million
Q3 2024

A detailed history of Marietta Investment Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Marietta Investment Partners LLC holds 7,939 shares of LLY stock, worth $5.79 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares

7,939

Previous 8,146 2.54%

Holding current value

$5.79 Million

Previous $7.38 Million 4.64%

% of portfolio

1.53%

Previous 1.63%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $159,832 - $198,724	-207 Reduced 2.54%	7,939 $7.03 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $2.49 Million - $3.12 Million	3,437 Added 72.99%	8,146 $7.38 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $439,412 - $587,871	742 Added 18.7%	4,709 $3.66 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $29,935 - $35,290	57 Added 1.46%	3,967 $2.31 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $22,485 - $27,904	100 Added 2.62%	3,910 $1.08 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $162,676 - $210,592	-990 Reduced 20.63%	3,810 $712,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $50,120 - $62,034	-421 Reduced 8.06%	4,800 $666,000
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $850,014 - $1.05 Million	-7,950 Reduced 60.36%	5,221 $686,000
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $245,617 - $267,168	-2,300 Reduced 14.87%	13,171 $1.47 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $11,079 - $12,932	-100 Reduced 0.64%	15,471 $1.71 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $1.03 Million - $1.15 Million	9,721 Added 166.17%	15,571 $1.8 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $502,281 - $627,763	5,850 New	5,850 $628,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $693B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marietta Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marietta Investment Partners LLC with notifications on news.

Account

Marietta Investment Partners LLC Eli Lilly & CO Transaction History